1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. SYNDAX PHARMACEUTICALS INC

Syndax Pharmaceuticals Inc

XNAS: SNDX

Download real time

12.70 -0.34 (-2.61%)

49.34% Fall from 52W High

501.6K XNAS Volume

XNAS 18 Mar, 2025 1:42 PM (EDT)

Watchlist

Portfolio

Share
3S
19W
1O
2T
1,092.5

Market Cap

High in industry
-3.4

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
3

Price to Book

Below industry Median
0.0

Beta 1Year

Very Low volatility


Insider Trading disclosures for Syndax Pharmaceuticals Inc

The latest disclosure was made by Michael Metzger in Syndax Pharmaceuticals Inc where a trade of 6,074 Common Stock done at an average price of $7.2 was reported to US exchanges on March 14, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 14 Mar 2025 6,074 306,195 (1%) 0% 7.2 43,733 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 6,074 0 - - Stock options (Right to buy)
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2025 7,814 0 - - Stock options (Right to buy)
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 04 Mar 2025 7,814 307,935 (1%) 0% 7.2 56,261 Common Stock
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.05 per share. 04 Mar 2025 7,814 300,121 (0%) 0% 15.0 117,564 Common Stock
Neil Gallagher President, Head of R&D Sale of securities on an exchange or to another person at price $ 15.50 per share. 10 Feb 2025 4,618 85,095 (0%) 0% 15.5 71,597 Common Stock
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.50 per share. 10 Feb 2025 13,288 300,121 (0%) 0% 15.5 206,017 Common Stock
Keith Goldan Chief Financial Officer Sale of securities on an exchange or to another person at price $ 15.50 per share. 10 Feb 2025 3,777 90,746 (0%) 0% 15.5 58,559 Common Stock
Dennis G. Podlesak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 50,000 191,763 (0%) 0% 0 Common Stock
Keith A. Katkin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 25,000 90,000 (0%) 0% 0 Common Stock
Pierre Legault Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 25,000 90,000 (0%) 0% 0 Common Stock
Michael Metzger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 60,500 224,409 (0%) 0% 0 Common Stock
Michael Metzger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 89,000 313,409 (1%) 0% 0 Common Stock
Michael Metzger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 364,000 364,000 - - Stock Options (Right to buy)
Keith Goldan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 18,500 71,123 (0%) 0% 0 Common Stock
Keith Goldan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 23,400 94,523 (0%) 0% 0 Common Stock
Keith Goldan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 110,500 110,500 - - Stock Options (Right to buy)
William Meury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 25,000 90,000 (0%) 0% 0 Common Stock
Martin H. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 25,000 74,000 (0%) 0% 0 Common Stock
Jennifer Ann Jarrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 25,000 90,000 (0%) 0% 0 Common Stock
Aleksandra Rizo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 25,000 25,000 (0%) 0% 0 Common Stock
Neil Gallagher President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 110,500 110,500 - - Stock Options (Right to buy)
Neil Gallagher President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 23,400 89,713 (0%) 0% 0 Common Stock
Neil Gallagher President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 18,500 66,313 (0%) 0% 0 Common Stock
Keith Goldan Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 20.03 per share. 14 Jun 2024 1,250 52,623 (0%) 0% 20.0 25,037 Common Stock
Aleksandra Rizo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 35,000 35,000 - - Stock Options (Right to buy)
Keith Goldan Chief Financial Officer Other type of transaction at price $ 18.12 per share. 07 Feb 2024 862 3,490 (0%) 0% 18.1 15,619 Common Stock
Keith Goldan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 11,700 51,373 (0%) 0% 0 Common Stock
Gallagher Neil President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 34,688 34,688 (0%) 0% 0 Common Stock
Michael Metzger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 214,500 214,500 - - Stock Options (Right to buy)
G. Dennis Podlesak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 34,000 141,763 (0%) 0% 0 Common Stock
Pierre Legault Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 17,000 65,000 (0%) 0% 0 Common Stock
Goldan Keith Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 70,000 70,000 - - Stock Options (Right to buy)
Keith Goldan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 35,000 39,673 (0%) 0% 0 Common Stock
Metzger Michael Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 107,250 124,909 (0%) 0% 0 Common Stock
Ann Jarrett Jennifer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 17,000 65,000 (0%) 0% 0 Common Stock
Gallagher Neil President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 69,375 69,375 - - Stock Options (Right to buy)
Neil Gallagher President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 13,125 47,813 (0%) 0% 0 Common Stock
Meury William Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 17,000 65,000 (0%) 0% 0 Common Stock
Metzger Michael Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 39,000 163,909 (0%) 0% 0 Common Stock
Huber H. Martin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 17,000 49,000 (0%) 0% 0 Common Stock
Katkin Keith A. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 17,000 65,000 (0%) 0% 0 Common Stock
Keith Goldan Chief Financial Officer Other type of transaction at price $ 17.42 per share. 07 Feb 2024 1,183 4,673 (0%) 0% 17.4 20,608 Common Stock
W. Briggs Morrison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 17,000 34,836 (0%) 0% 0 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.77 per share. 09 Aug 2023 52,855 70,691 (0%) 0% 8.8 463,538 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Aug 2023 52,855 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director Sale of securities on an exchange or to another person at price $ 18.27 per share. 09 Aug 2023 52,855 17,836 (0%) 0% 18.3 965,402 Common Stock
William Meury Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.11 per share. 02 Aug 2023 35,000 83,000 (0%) 0% 7.1 248,850 Common Stock
William Meury Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2023 35,000 0 - - Stock Options (Right to buy)
William Meury Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2023 24,000 0 - - Stock Options (Right to buy)
William Meury Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2023 24,000 0 - - Stock Options (Right to buy)
William Meury Director Sale of securities on an exchange or to another person at price $ 20.45 per share. 02 Aug 2023 24,000 48,000 (0%) 0% 20.5 490,913 Common Stock
William Meury Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.47 per share. 02 Aug 2023 24,000 72,000 (0%) 0% 9.5 227,280 Common Stock
William Meury Director Sale of securities on an exchange or to another person at price $ 20.46 per share. 02 Aug 2023 24,000 48,000 (0%) 0% 20.5 490,951 Common Stock
William Meury Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.88 per share. 02 Aug 2023 24,000 72,000 (0%) 0% 7.9 189,120 Common Stock
William Meury Director Sale of securities on an exchange or to another person at price $ 20.46 per share. 02 Aug 2023 35,000 48,000 (0%) 0% 20.5 715,946 Common Stock
Briggs W. Morrison Director Sale of securities on an exchange or to another person at price $ 20.40 per share. 10 Jul 2023 52,855 17,836 (0%) 0% 20.4 1,078,068 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2023 52,855 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.77 per share. 10 Jul 2023 52,855 70,691 (0%) 0% 8.8 463,538 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2023 28,273 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2023 24,582 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director Sale of securities on an exchange or to another person at price $ 21.18 per share. 09 Jun 2023 28,273 17,836 (0%) 0% 21.2 598,797 Common Stock
Briggs W. Morrison Director Sale of securities on an exchange or to another person at price $ 21.18 per share. 09 Jun 2023 24,582 46,109 (0%) 0% 21.2 520,625 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.77 per share. 09 Jun 2023 28,273 70,691 (0%) 0% 8.8 247,954 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 09 Jun 2023 24,582 42,418 (0%) 0% 6.4 156,833 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 09 May 2023 52,855 70,691 (0%) 0% 6.4 337,215 Common Stock
Briggs W. Morrison Director Sale of securities on an exchange or to another person at price $ 21.41 per share. 09 May 2023 52,855 17,836 (0%) 0% 21.4 1,131,478 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 May 2023 52,855 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director Sale of securities on an exchange or to another person at price $ 19.53 per share. 10 Apr 2023 52,855 17,836 (0%) 0% 19.5 1,032,237 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 10 Apr 2023 52,855 70,691 (0%) 0% 6.4 337,215 Common Stock
Briggs W. Morrison Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Apr 2023 52,855 0 - - Stock Options (Right to buy)
Neil Gallagher President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2023 250,000 250,000 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 13 Mar 2023 52,854 70,690 (0%) 0% 6.4 337,209 Common Stock
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 22.53 per share. 13 Mar 2023 52,854 17,836 (0%) 0% 22.5 1,190,674 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2023 52,854 0 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2023 17,428 0 - - Stock Options (Right to buy)
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 15 Feb 2023 7,572 7,572 (0%) 0% 6.4 48,309 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 25.84 per share. 15 Feb 2023 7,572 0 (0%) 0% 25.8 195,688 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 15 Feb 2023 17,428 17,428 (0%) 0% 7.2 125,482 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 25.84 per share. 15 Feb 2023 17,428 0 (0%) 0% 25.8 450,404 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2023 7,572 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2023 5,959 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 27.64 per share. 06 Feb 2023 5,959 17,659 (0%) 0% 27.6 164,697 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 06 Feb 2023 5,959 23,618 (0%) 0% 6.4 38,018 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 06 Feb 2023 52,854 70,690 (0%) 0% 6.4 337,209 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2023 52,854 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 26.83 per share. 06 Feb 2023 52,854 17,836 (0%) 0% 26.8 1,417,909 Common Stock
Dennis G. Podlesak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 32,000 107,763 (0%) 0% 0 Common Stock
Keith A. Katkin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 16,000 48,000 (0%) 0% 0 Common Stock
Pierre Legault Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 16,000 48,000 (0%) 0% 0 Common Stock
Michael Metzger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 410,000 410,000 - - Stock Options (Right to buy)
Keith Goldan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 110,000 110,000 - - Stock Options (Right to buy)
William Meury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 16,000 48,000 (0%) 0% 0 Common Stock
Briggs W. Morrison Director, President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 32,000 32,000 - - Stock Options (Right to buy)
Martin H. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 16,000 32,000 (0%) 0% 0 Common Stock
Jennifer Ann Jarrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 16,000 48,000 (0%) 0% 0 Common Stock
Alexander Nolte Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 17,000 17,000 - - Stock Options (Right to buy)
Catherine Madigan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 110,000 110,000 - - Stock Options (Right to buy)
Peter Ordentlich Chief Scientific Officer Other type of transaction at price $ 17.32 per share. 31 Jan 2023 69 69 (0%) 0% 17.3 1,195 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 28.43 per share. 31 Jan 2023 69 0 (0%) 0% 28.4 1,962 Common Stock
Peter Ordentlich Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 90,000 90,000 - - Stock Options (Right to buy)
Pierre Legault Director Sale of securities on an exchange or to another person at price $ 26.74 per share. 12 Jan 2023 24,000 32,000 (0%) 0% 26.7 641,782 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jan 2023 5,000 0 - - Stock Options (Right to buy)
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jan 2023 10,000 0 - - Stock Options (Right to buy)
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jan 2023 24,000 0 - - Stock Options (Right to buy)
Pierre Legault Director Sale of securities on an exchange or to another person at price $ 27.00 per share. 12 Jan 2023 5,000 32,000 (0%) 0% 27 135,000 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.58 per share. 12 Jan 2023 5,000 37,000 (0%) 0% 13.6 67,900 Common Stock
Pierre Legault Director Sale of securities on an exchange or to another person at price $ 27.00 per share. 12 Jan 2023 10,000 32,000 (0%) 0% 27 270,000 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.58 per share. 12 Jan 2023 10,000 42,000 (0%) 0% 13.6 135,800 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.47 per share. 12 Jan 2023 24,000 56,000 (0%) 0% 9.5 227,280 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.35 per share. 01 Dec 2022 3,772 4,037 (0%) 0% 6.3 23,952 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2022 17,200 0 - - Stock Options (Right to buy)
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2022 3,772 0 - - Stock Options (Right to buy)
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2022 4,028 0 - - Stock Options (Right to buy)
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 25.05 per share. 01 Dec 2022 17,200 265 (0%) 0% 25.1 430,936 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 01 Dec 2022 17,200 17,465 (0%) 0% 6.4 109,736 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 25.01 per share. 01 Dec 2022 4,028 265 (0%) 0% 25.0 100,746 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 01 Dec 2022 4,028 4,293 (0%) 0% 6.4 25,699 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 25.01 per share. 01 Dec 2022 3,772 265 (0%) 0% 25.0 94,343 Common Stock
Keith A. Katkin Director Sale of securities on an exchange or to another person at price $ 25.90 per share. 06 Oct 2022 20,782 32,000 (0%) 0% 25.9 538,273 Common Stock
Keith A. Katkin Director Sale of securities on an exchange or to another person at price $ 25.90 per share. 06 Oct 2022 9,117 32,000 (0%) 0% 25.9 236,139 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. 06 Oct 2022 9,117 41,117 (0%) 0% 8.9 81,415 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.88 per share. 06 Oct 2022 20,782 52,782 (0%) 0% 7.9 163,762 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Oct 2022 20,782 0 - - Stock Options (Right to buy)
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Oct 2022 9,117 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Oct 2022 16,231 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 25.29 per share. 06 Oct 2022 16,231 17,659 (0%) 0% 25.3 410,508 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.77 per share. 06 Oct 2022 16,231 33,890 (0%) 0% 8.8 142,346 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.88 per share. 30 Sep 2022 137 32,137 (0%) 0% 7.9 1,080 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 137 0 - - Stock Options (Right to buy)
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 223 0 - - Stock Options (Right to buy)
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 167 0 - - Stock Options (Right to buy)
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 13 0 - - Stock Options (Right to buy)
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 2,914 0 - - Stock Options (Right to buy)
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 647 0 - - Stock Options (Right to buy)
Keith A. Katkin Director Sale of securities on an exchange or to another person at price $ 25.00 per share. 30 Sep 2022 223 32,000 (0%) 0% 25 5,575 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. 30 Sep 2022 223 32,223 (0%) 0% 8.9 1,991 Common Stock
Keith A. Katkin Director Sale of securities on an exchange or to another person at price $ 25.00 per share. 30 Sep 2022 137 32,000 (0%) 0% 25 3,425 Common Stock
Keith A. Katkin Director Sale of securities on an exchange or to another person at price $ 25.00 per share. 30 Sep 2022 13 32,000 (0%) 0% 25 325 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.92 per share. 30 Sep 2022 13 32,013 (0%) 0% 8.9 116 Common Stock
Keith A. Katkin Director Sale of securities on an exchange or to another person at price $ 25.00 per share. 30 Sep 2022 167 32,000 (0%) 0% 25 4,175 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.88 per share. 30 Sep 2022 167 32,167 (0%) 0% 7.9 1,316 Common Stock
Keith A. Katkin Director Sale of securities on an exchange or to another person at price $ 25.07 per share. 30 Sep 2022 647 32,000 (0%) 0% 25.1 16,221 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. 30 Sep 2022 647 32,647 (0%) 0% 8.9 5,778 Common Stock
Keith A. Katkin Director Sale of securities on an exchange or to another person at price $ 25.07 per share. 30 Sep 2022 2,914 32,000 (0%) 0% 25.1 73,056 Common Stock
Keith A. Katkin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.88 per share. 30 Sep 2022 2,914 34,914 (0%) 0% 7.9 22,962 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 29,606 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.77 per share. 30 Sep 2022 29,606 47,265 (0%) 0% 8.8 259,645 Common Stock
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 25.02 per share. 30 Sep 2022 29,606 17,659 (0%) 0% 25.0 740,757 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.77 per share. 30 Sep 2022 2,883 20,542 (0%) 0% 8.8 25,284 Common Stock
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 25.01 per share. 30 Sep 2022 2,883 17,659 (0%) 0% 25.0 72,107 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.77 per share. 30 Sep 2022 1,280 18,939 (0%) 0% 8.8 11,226 Common Stock
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 25.02 per share. 30 Sep 2022 1,280 17,659 (0%) 0% 25.0 32,026 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 1,280 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2022 2,883 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 23.03 per share. 19 Sep 2022 114,339 17,836 (0%) 0% 23.0 2,633,044 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Sep 2022 59,649 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Sep 2022 114,339 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 23.25 per share. 19 Sep 2022 59,649 17,836 (0%) 0% 23.3 1,387,012 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.90 per share. 19 Sep 2022 59,649 77,485 (0%) 0% 10.9 650,174 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.90 per share. 19 Sep 2022 114,339 132,175 (0%) 0% 10.9 1,246,295 Common Stock
Dennis G. Podlesak Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2022 5,419 0 - - Stock Options (Right to buy)
Dennis G. Podlesak Director Sale of securities on an exchange or to another person at price $ 23.43 per share. 15 Sep 2022 6,556 75,763 (0%) 0% 23.4 153,625 Common Stock
Dennis G. Podlesak Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2022 66,840 0 - - Stock Options (Right to buy)
Dennis G. Podlesak Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2022 6,556 0 - - Stock Options (Right to buy)
Dennis G. Podlesak Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.35 per share. 15 Sep 2022 6,556 82,319 (0%) 0% 6.4 41,631 Common Stock
Dennis G. Podlesak Director Sale of securities on an exchange or to another person at price $ 23.43 per share. 15 Sep 2022 5,419 75,763 (0%) 0% 23.4 126,982 Common Stock
Dennis G. Podlesak Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. 15 Sep 2022 5,419 81,182 (0%) 0% 6.3 34,248 Common Stock
Dennis G. Podlesak Director Sale of securities on an exchange or to another person at price $ 24.20 per share. 15 Sep 2022 66,840 75,763 (0%) 0% 24.2 1,617,381 Common Stock
Dennis G. Podlesak Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. 15 Sep 2022 66,840 142,603 (0%) 0% 6.3 422,429 Common Stock
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 23.80 per share. 14 Sep 2022 87,645 17,836 (0%) 0% 23.8 2,085,855 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 14 Sep 2022 87,645 105,481 (0%) 0% 7.2 631,044 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 14 Sep 2022 66,775 84,611 (0%) 0% 7.2 480,780 Common Stock
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 24.20 per share. 14 Sep 2022 66,775 17,836 (0%) 0% 24.2 1,616,035 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 14 Sep 2022 71,966 89,802 (0%) 0% 7.2 518,155 Common Stock
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 23.22 per share. 14 Sep 2022 71,966 17,836 (0%) 0% 23.2 1,671,015 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.90 per share. 14 Sep 2022 53,034 70,870 (0%) 0% 10.9 578,071 Common Stock
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 23.22 per share. 14 Sep 2022 53,034 17,836 (0%) 0% 23.2 1,231,423 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Sep 2022 87,645 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Sep 2022 66,775 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Sep 2022 53,034 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Sep 2022 71,966 0 - - Stock Options (Right to buy)
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.63 per share. 05 Aug 2022 10,000 42,000 (0%) 0% 9.6 96,300 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2022 14,000 0 - - Stock Options (Right to buy)
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2022 10,000 0 - - Stock Options (Right to buy)
Pierre Legault Director Sale of securities on an exchange or to another person at price $ 23.02 per share. 05 Aug 2022 14,000 32,000 (0%) 0% 23.0 322,223 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. 05 Aug 2022 14,000 46,000 (0%) 0% 8.9 125,020 Common Stock
Pierre Legault Director Sale of securities on an exchange or to another person at price $ 23.02 per share. 05 Aug 2022 10,000 32,000 (0%) 0% 23.0 230,159 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. 29 Jul 2022 22,846 23,111 (0%) 0% 6.3 144,387 Common Stock
Peter Ordentlich Chief Scientific Officer Other type of transaction at price $ 14.12 per share. 29 Jul 2022 265 265 (0%) 0% 14.1 3,742 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jul 2022 22,846 0 - - Stock Options (Right to buy)
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jul 2022 2,154 0 - - Stock Options (Right to buy)
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 25.04 per share. 29 Jul 2022 2,154 265 (0%) 0% 25.0 53,927 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.35 per share. 29 Jul 2022 2,154 2,419 (0%) 0% 6.4 13,678 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 25.04 per share. 29 Jul 2022 22,846 265 (0%) 0% 25.0 571,966 Common Stock
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 21.06 per share. 25 Jul 2022 19,764 17,659 (0%) 0% 21.1 416,139 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2022 11,838 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2022 19,764 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 21.06 per share. 25 Jul 2022 11,838 17,659 (0%) 0% 21.1 249,254 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 25 Jul 2022 11,838 29,497 (0%) 0% 6.4 75,526 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 25 Jul 2022 19,764 37,423 (0%) 0% 6.4 126,094 Common Stock
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 21.07 per share. 06 Jul 2022 15,009 17,659 (0%) 0% 21.1 316,307 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jul 2022 100 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jul 2022 15,009 0 - - Stock Options (Right to buy)
Michael Metzger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 21.00 per share. 06 Jul 2022 100 17,659 (0%) 0% 21 2,100 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 06 Jul 2022 100 17,759 (0%) 0% 6.4 638 Common Stock
Michael Metzger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 06 Jul 2022 15,009 32,668 (0%) 0% 6.4 95,757 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2022 62,292 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Sale of securities on an exchange or to another person at price $ 19.00 per share. 01 Jul 2022 62,292 17,836 (0%) 0% 19.0 1,183,430 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 01 Jul 2022 62,292 80,128 (0%) 0% 7.2 448,502 Common Stock
Keith Goldan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 230,000 230,000 - - Stock Options (Right to buy)
Keith Goldan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 3,205 3,205 (0%) 0% 0 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 01 Apr 2022 70,545 88,381 (0%) 0% 7.2 507,924 Common Stock
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2022 3,128 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2022 70,545 0 - - Stock Options (Right to buy)
Briggs W. Morrison Director, President, Head of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 01 Apr 2022 3,128 20,964 (0%) 0% 7.2 22,522 Common Stock
Catherine Madigan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 180,000 180,000 - - Stock Options (Right to buy)
Dennis G. Podlesak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 32,000 75,763 (0%) 0% 0 Common Stock
Keith A. Katkin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 16,000 32,000 (0%) 0% 0 Common Stock
Pierre Legault Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 16,000 32,000 (0%) 0% 0 Common Stock
Michael Metzger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 325,000 325,000 - - Stock Options (Right to buy)
William Meury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 16,000 32,000 (0%) 0% 0 Common Stock
Briggs W. Morrison Director, President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 160,000 160,000 - - Stock Options (Right to buy)
Martin H. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 16,000 16,000 (0%) 0% 0 Common Stock
Michael L. Meyers SVP, Chief Medical Officer Other type of transaction at price $ 12.39 per share. 02 Feb 2022 1,714 23,280 (0%) 0% 12.4 21,236 Common Stock
Michael L. Meyers SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 17,350 17,350 - - Stock Options (Right to buy)
Fabrice Egros Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 16,000 32,000 (0%) 0% 0 Common Stock
Jennifer Ann Jarrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 16,000 32,000 (0%) 0% 0 Common Stock
Peter Ordentlich Chief Scientific Officer Other type of transaction at price $ 12.39 per share. 01 Feb 2022 1,412 1,412 (0%) 0% 12.4 17,495 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 16.65 per share. 01 Feb 2022 1,412 0 (0%) 0% 16.7 23,510 Common Stock
Peter Ordentlich Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 80,000 80,000 - - Stock Options (Right to buy)
Alexander Nolte Chief Accounting Officer Other type of transaction at price $ 12.39 per share. 01 Feb 2022 968 968 (0%) 0% 12.4 11,994 Common Stock
Alexander Nolte Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 30,000 30,000 - - Stock Options (Right to buy)
Alexander Nolte Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 16.65 per share. 01 Feb 2022 968 0 (0%) 0% 16.6 16,117 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Dec 2021 20,000 0 - - Stock Options (Right to buy)
Pierre Legault Director Sale of securities on an exchange or to another person at price $ 22.01 per share. 20 Dec 2021 24,000 16,000 (0%) 0% 22.0 528,206 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.88 per share. 20 Dec 2021 24,000 40,000 (0%) 0% 7.9 189,120 Common Stock
Pierre Legault Director Sale of securities on an exchange or to another person at price $ 21.01 per share. 20 Dec 2021 20,000 16,000 (0%) 0% 21.0 420,250 Common Stock
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Dec 2021 24,000 0 - - Stock Options (Right to buy)
Pierre Legault Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.08 per share. 20 Dec 2021 20,000 36,000 (0%) 0% 7.1 141,600 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.90 per share. 17 Dec 2021 35,156 83,492 (0%) 0% 10.9 383,200 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2021 35,156 0 - - Stock Options (Right to buy)
Briggs Morrison Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.00 per share. 17 Dec 2021 35,156 48,336 (0%) 0% 20 703,120 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2021 1,676 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2021 22,715 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 20.29 per share. 16 Dec 2021 45,000 17,659 (0%) 0% 20.3 912,960 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.77 per share. 16 Dec 2021 45,000 62,659 (0%) 0% 8.8 394,650 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 20.29 per share. 16 Dec 2021 16,000 17,659 (0%) 0% 20.3 324,608 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 16 Dec 2021 16,000 33,659 (0%) 0% 6.4 102,080 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.02 per share. 16 Dec 2021 1,676 17,659 (0%) 0% 19.0 31,877 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 16 Dec 2021 1,676 19,335 (0%) 0% 6.4 10,693 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.08 per share. 16 Dec 2021 22,715 17,659 (0%) 0% 19.1 433,400 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 16 Dec 2021 22,715 40,374 (0%) 0% 6.4 144,922 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2021 45,000 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2021 16,000 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share. 13 Dec 2021 34,564 52,223 (0%) 0% 6.4 220,518 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Dec 2021 34,564 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Dec 2021 2,045 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.05 per share. 13 Dec 2021 34,564 17,659 (0%) 0% 19.1 658,555 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.05 per share. 13 Dec 2021 2,045 17,659 (0%) 0% 19.1 38,964 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 13 Dec 2021 2,045 19,704 (0%) 0% 7.2 14,724 Common Stock
Fabrice Egros Director Sale of securities on an exchange or to another person at price $ 18.03 per share. 18 Nov 2021 14,000 16,000 (0%) 0% 18.0 252,452 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. 18 Nov 2021 14,000 30,000 (0%) 0% 8.9 125,020 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Nov 2021 30 0 - - Stock Options (Right to buy)
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Nov 2021 14,000 0 - - Stock Options (Right to buy)
Fabrice Egros Director Sale of securities on an exchange or to another person at price $ 18.03 per share. 18 Nov 2021 30 16,000 (0%) 0% 18.0 541 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. 18 Nov 2021 30 16,030 (0%) 0% 7.9 236 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 25 Oct 2021 16,296 33,955 (0%) 0% 7.2 117,331 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.13 per share. 25 Oct 2021 44,704 17,659 (0%) 0% 19.1 855,335 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 25 Oct 2021 44,704 62,363 (0%) 0% 7.2 321,869 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2021 16,296 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2021 44,704 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.20 per share. 25 Oct 2021 16,296 17,659 (0%) 0% 19.2 312,825 Common Stock
Dennis G. Podlesak Director Other type of transaction at price $ 0.00 per share. 05 Oct 2021 463 43,763 (0%) 0% 0 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Sep 2021 24,437 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 27 Sep 2021 24,437 42,096 (0%) 0% 7.2 175,946 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.51 per share. 27 Sep 2021 24,437 17,659 (0%) 0% 19.5 476,832 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.02 per share. 20 Sep 2021 300 17,659 (0%) 0% 19.0 5,706 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 20 Sep 2021 31,455 49,114 (0%) 0% 7.2 226,476 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.24 per share. 20 Sep 2021 31,455 17,659 (0%) 0% 19.2 605,046 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 20 Sep 2021 4,808 22,467 (0%) 0% 7.2 34,618 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.16 per share. 20 Sep 2021 4,808 17,659 (0%) 0% 19.2 92,108 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 20 Sep 2021 300 17,959 (0%) 0% 7.2 2,160 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2021 31,455 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2021 4,808 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2021 300 0 - - Stock Options (Right to buy)
Briggs Morrison Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.00 per share. 17 Sep 2021 50 48,336 (0%) 0% 20 1,000 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Sep 2021 50 0 - - Stock Options (Right to buy)
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Sep 2021 70,262 0 - - Stock Options (Right to buy)
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 17 Sep 2021 70,262 118,598 (0%) 0% 7.2 505,886 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 17 Sep 2021 50 48,386 (0%) 0% 7.2 360 Common Stock
Briggs Morrison Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.07 per share. 17 Sep 2021 70,262 48,336 (0%) 0% 20.1 1,410,018 Common Stock
Martin H. Huber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2021 35,000 35,000 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.02 per share. 13 Sep 2021 16,651 17,659 (0%) 0% 19.0 316,639 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 44,349 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2021 16,651 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 19.15 per share. 13 Sep 2021 44,349 17,659 (0%) 0% 19.2 849,394 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 13 Sep 2021 44,349 62,008 (0%) 0% 7.2 319,313 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 13 Sep 2021 16,651 34,310 (0%) 0% 7.2 119,887 Common Stock
Fabrice Egros Director Sale of securities on an exchange or to another person at price $ 15.75 per share. 18 Aug 2021 15,635 16,000 (0%) 0% 15.8 246,328 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2021 15,635 0 - - Stock Options (Right to buy)
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.88 per share. 18 Aug 2021 15,635 31,635 (0%) 0% 7.9 123,204 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.88 per share. 18 May 2021 1,683 29,609 (0%) 0% 7.9 13,262 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2021 11,926 0 - - Stock Options (Right to buy)
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2021 1,683 0 - - Stock Options (Right to buy)
Fabrice Egros Director Sale of securities on an exchange or to another person at price $ 18.65 per share. 18 May 2021 1,683 16,000 (0%) 0% 18.6 31,385 Common Stock
Fabrice Egros Director Sale of securities on an exchange or to another person at price $ 18.65 per share. 18 May 2021 11,926 17,683 (0%) 0% 18.6 222,398 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 18 May 2021 11,926 27,926 (0%) 0% 7.2 85,867 Common Stock
Michael L. Meyers SVP, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 15.46 per share. 26 Apr 2021 500 15,666 (0%) 0% 15.5 7,730 Common Stock
Dennis G. Podlesak Director Purchase of securities on an exchange or from another person at price $ 14.11 per share. 22 Apr 2021 13,967 43,300 (0%) 0% 14.1 197,077 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2021 10,167 0 - - Stock Options (Right to buy)
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2021 74 0 - - Stock Options (Right to buy)
Fabrice Egros Director Sale of securities on an exchange or to another person at price $ 24.31 per share. 01 Mar 2021 74 16,000 (0%) 0% 24.3 1,799 Common Stock
Fabrice Egros Director Sale of securities on an exchange or to another person at price $ 24.31 per share. 01 Mar 2021 10,167 16,074 (0%) 0% 24.3 247,182 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 01 Mar 2021 74 26,241 (0%) 0% 7.2 533 Common Stock
Fabrice Egros Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.35 per share. 01 Mar 2021 10,167 26,167 (0%) 0% 6.3 64,560 Common Stock
Briggs Morrison Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.55 per share. 08 Feb 2021 35,156 48,336 (0%) 0% 20.5 722,403 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 08 Feb 2021 35,156 83,492 (0%) 0% 7.2 253,123 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2021 35,156 0 - - Stock Options (Right to buy)
Dennis G. Podlesak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 29,333 29,333 (0%) 0% 0 Common Stock
Keith A. Katkin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 16,000 16,000 (0%) 0% 0 Common Stock
Pierre Legault Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 16,000 16,000 (0%) 0% 0 Common Stock
Michael Metzger Director, President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 160,000 160,000 - - Stock Option (Right to Buy)
William Meury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 16,000 16,000 (0%) 0% 0 Common Stock
Briggs Morrison Director, Chief Executive Officer Other type of transaction at price $ 12.00 per share. 03 Feb 2021 1,771 48,336 (0%) 0% 12 21,252 Common Stock
Briggs Morrison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 195,000 195,000 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 80,000 80,000 - - Stock Option (Right to Buy)
Michael L. Meyers SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 80,000 80,000 - - Stock Option (Right to Buy)
Michael L. Meyers SVP, Chief Medical Officer Other type of transaction at price $ 12.00 per share. 03 Feb 2021 1,771 15,166 (0%) 0% 12 21,252 Common Stock
Michael L. Meyers SVP, Chief Medical Officer Other type of transaction at price $ 7.97 per share. 03 Feb 2021 2,665 13,395 (0%) 0% 8.0 21,240 Common Stock
Fabrice Egros Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 16,000 16,000 (0%) 0% 0 Common Stock
Jennifer Jarrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 16,000 16,000 (0%) 0% 0 Common Stock
Daphne Karydas Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 95,000 95,000 - - Stock Option (Right to Buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2021 15,000 0 - - Stock Options (Right to buy)
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 01 Feb 2021 15,000 32,659 (0%) 0% 7.2 108,000 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 20.19 per share. 01 Feb 2021 15,000 17,659 (0%) 0% 20.2 302,799 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2020 15,000 0 - - Employee Stock Option (right to buy)
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 22.97 per share. 01 Dec 2020 15,000 17,659 (0%) 0% 23.0 344,513 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 01 Dec 2020 15,000 32,659 (0%) 0% 7.2 108,000 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 22.89 per share. 23 Nov 2020 16,334 0 (0%) 0% 22.9 373,924 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 23.58 per share. 23 Nov 2020 7,954 16,334 (0%) 0% 23.6 187,594 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 23.33 per share. 23 Nov 2020 5,684 24,288 (0%) 0% 23.3 132,603 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.08 per share. 23 Nov 2020 24,288 24,288 (0%) 0% 3.1 74,807 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.08 per share. 23 Nov 2020 5,684 29,972 (0%) 0% 3.1 17,507 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Nov 2020 5,684 0 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Nov 2020 24,288 0 - - Stock Option (Right to Buy)
Briggs Morrison Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.04 per share. 09 Nov 2020 62,938 46,565 (0%) 0% 20.0 1,261,265 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Nov 2020 17,466 0 - - Stock Options (Right to buy)
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Nov 2020 62,938 0 - - Stock Options (Right to buy)
Briggs Morrison Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.06 per share. 09 Nov 2020 17,466 46,565 (0%) 0% 20.1 350,312 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 09 Nov 2020 17,466 64,031 (0%) 0% 7.2 125,755 Common Stock
Briggs Morrison Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 09 Nov 2020 62,938 109,503 (0%) 0% 7.2 453,154 Common Stock
Michael Metzger Director, President and COO Sale of securities on an exchange or to another person at price $ 20.31 per share. 04 Nov 2020 100,000 17,659 (0%) 0% 20.3 2,031,410 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.20 per share. 04 Nov 2020 100,000 117,659 (0%) 0% 7.2 720,000 Common Stock
Michael Metzger Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Nov 2020 100,000 0 - - Stock Options (Right to buy)
Michael L. Meyers SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2020 3,500 10,730 (0%) 0% 0 Common Stock
Dennis G. Podlesak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 44,000 44,000 - - Stock Option (Right to Buy)
Keith A. Katkin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 24,000 24,000 - - Stock Option (Right to Buy)
Pierre Legault Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 24,000 24,000 - - Stock Option (Right to Buy)
Richard P. Shea Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 43,200 43,200 - - Stock Option (Right to Buy)
Richard P. Shea Chief Financial Officer Other type of transaction at price $ 4.89 per share. 12 Feb 2020 1,401 5,616 (0%) 0% 4.9 6,851 Common Stock
Richard P. Shea Chief Financial Officer Other type of transaction at price $ 7.97 per share. 12 Feb 2020 1,505 7,121 (0%) 0% 8.0 11,995 Common Stock
Michael Metzger Director, President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 15,000 17,659 (0%) 0% 0 Common Stock
Michael Metzger Director, President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 140,000 140,000 - - Stock Option (Right to Buy)
William Meury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 24,000 24,000 - - Stock Option (Right to Buy)
Briggs Morrison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 194,000 194,000 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 50,000 50,000 - - Stock Option (Right to Buy)
Michael L. Meyers SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 50,825 50,825 - - Stock Option (Right to Buy)
Fabrice Egros Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 24,000 24,000 - - Stock Option (Right to Buy)
Jennifer Jarrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 24,000 24,000 - - Stock Option (Right to Buy)
Briggs Morrison Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 8.00 per share. 04 Feb 2020 12,500 43,900 (0%) 0% 8 100,000 Common Stock
Briggs Morrison Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.40 per share. 10 Oct 2019 11,000 31,400 (0%) 0% 5.4 59,400 Common Stock
Michael Metzger Director, President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jul 2019 200,000 200,000 - - Stock Option (Right to Buy)
Dennis G. Podlesak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2019 44,000 44,000 - - Stock Option (Right to Buy)
Keith A. Katkin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2019 24,000 24,000 - - Stock Option (Right to Buy)
Pierre Legault None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2019 24,000 24,000 - - Stock Option (Right to Buy)
William Meury None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2019 24,000 24,000 - - Stock Option (Right to Buy)
Fabrice Egros None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2019 24,000 24,000 - - Stock Option (Right to Buy)
Jennifer Jarrett None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2019 24,000 24,000 - - Stock Option (Right to Buy)
Briggs Morrison Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 7.56 per share. 09 May 2019 13,200 13,200 (0%) 0% 7.6 99,726 Common Stock
Briggs Morrison Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 7.29 per share. 09 May 2019 7,200 20,400 (0%) 0% 7.3 52,517 Common Stock
Michael L. Meyers SVP, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.88 per share. 21 Mar 2019 8 7,230 (0%) 0% 4.9 39 Common Stock
Richard P. Shea Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2019 91,200 91,200 - - Stock Option (Right to Buy)
Richard P. Shea Chief Financial Officer Other type of transaction at price $ 4.76 per share. 06 Feb 2019 2,521 4,215 (0%) 0% 4.8 12,000 Common Stock
Michael Metzger President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2019 240,000 240,000 - - Stock Option (Right to Buy)
Michael Metzger President and COO Other type of transaction at price $ 4.76 per share. 06 Feb 2019 2,659 2,659 (0%) 0% 4.8 12,657 Common Stock
Briggs Morrison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2019 354,000 354,000 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2019 80,000 80,000 - - Stock Option (Right to Buy)
Michael L. Meyers SVP, Chief Medical Officer Other type of transaction at price $ 4.76 per share. 06 Feb 2019 3,720 6,118 (0%) 0% 4.8 17,707 Common Stock
Michael L. Meyers SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2019 104,325 104,325 - - Stock Option (Right to Buy)
Michael L. Meyers SVP, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.79 per share. 30 Oct 2018 200 2,398 (0%) 0% 4.8 958 Common Stock
William Meury None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Sep 2018 35,000 35,000 - - Stock Option (Right to Buy)
Jennifer Jarrett None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Sep 2018 35,000 35,000 - - Stock Option (Right to Buy)
Dennis G. Podlesak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 14,000 14,000 - - Stock Option (Right to Buy)
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 14,000 14,000 - - Stock Option (Right to Buy)
Keith A. Katkin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 14,000 14,000 - - Stock Option (Right to Buy)
Pierre Legault None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 14,000 14,000 - - Stock Option (Right to Buy)
Henry Chen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 14,000 14,000 - - Stock Option (Right to Buy)
Fabrice Egros None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2018 14,000 14,000 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Apr 2018 7,500 0 - - Employee Stock Option (right to buy)
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.08 per share. 03 Apr 2018 7,500 7,500 (0%) 0% 3.1 23,100 Common Stock
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 03 Apr 2018 7,500 0 (0%) 0% 15 112,500 Common Stock
Richard P. Shea Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 48,000 48,000 - - Stock Option (Right to Buy)
Michael Metzger President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 125,000 125,000 - - Stock Option (Right to Buy)
Briggs Morrison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 200,000 200,000 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 40,000 40,000 - - Stock Option (Right to Buy)
Michael L. Meyers SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2018 75,000 75,000 - - Stock Option (Right to Buy)
Dennis G. Podlesak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2018 10,000 10,000 - - Stock Option (Right to Buy)
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2018 10,000 10,000 - - Stock Option (Right to Buy)
Keith A. Katkin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2018 10,000 10,000 - - Stock Option (Right to Buy)
Pierre Legault None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2018 10,000 10,000 - - Stock Option (Right to Buy)
Henry Chen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2018 10,000 10,000 - - Stock Option (Right to Buy)
Fabrice Egros None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2018 10,000 10,000 - - Stock Option (Right to Buy)
Dennis G. Podlesak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 5,000 5,000 - - Stock Option (Right to Buy)
Dennis G. Podlesak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 10,000 10,000 - - Stock Option (Right to Buy)
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 10,000 10,000 - - Stock Option (Right to Buy)
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 5,000 5,000 - - Stock Option (Right to Buy)
Keith A. Katkin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 10,000 10,000 - - Stock Option (Right to Buy)
Pierre Legault None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 10,000 10,000 - - Stock Option (Right to Buy)
Pierre Legault None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 5,000 5,000 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 17 May 2017 5,000 0 (0%) 0% 15 75,000 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.08 per share. 17 May 2017 732 5,000 (0%) 0% 3.1 2,255 Common Stock
Peter Ordentlich Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 732 0 - - Employee Stock Option (right to buy)
Henry Chen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 5,000 5,000 - - Stock Option (Right to Buy)
Henry Chen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 10,000 10,000 - - Stock Option (Right to Buy)
George W. Sledge None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 5,000 5,000 - - Stock Options (Right to buy)
Fabrice Egros None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 5,000 5,000 - - Stock Option (Right to Buy)
Fabrice Egros None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 10,000 10,000 - - Stock Option (Right to Buy)
Keith A. Katkin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2017 25,000 25,000 - - Stock Option (Right to Buy)
Ivor Royston None Sale or transfer of securities back to the company at price $ 13.75 per share. 20 Mar 2017 125,000 625,545 (3%) 0% 13.8 1,718,750 Common Stock
Richard P. Shea Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2017 125,000 125,000 - - Stock Option (Right to Buy)
Michael Metzger President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 95,000 95,000 - - Stock Option (Right to Buy)
Briggs Morrison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 160,000 160,000 - - Stock Option (Right to Buy)
Peter Ordentlich Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 20,000 20,000 - - Stock Option (Right to Buy)
Michael L. Meyers SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 66,100 66,100 - - Stock Option (Right to Buy)
Pierre Legault None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2017 20,000 20,000 - - Stock Option (Right to Buy)
Ivor Royston None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,000 8,000 - - Stock Option (Right to Buy)
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,000 8,000 - - Stock Option (Right to Buy)
Dennis G. Podlesak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,000 8,000 - - Stock Option (Right to Buy)
Richard P. Shea None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,000 8,000 - - Stock Option (Right to Buy)
Kim P. Kamdar Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,000 8,000 - - Stock Option (Right to Buy)
Henry Chen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,000 8,000 - - Stock Options (Right to buy)
George W. Sledge None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,000 8,000 - - Stock Option (Right to Buy)
Fabrice Egros None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2016 8,000 8,000 - - Stock Option (Right to Buy)
Ansbert Gadicke Ten Percent Owner 08 Mar 2016 1,138,210 1,138,210 - - Common Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 360,640 0 - - Series C-1 Preferred Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 2,967 0 - - Series B-1 Preferred Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 1,743,854 1,743,854 - - Common Stock
Ansbert Gadicke Ten Percent Owner 08 Mar 2016 1,138,210 0 - - Series A-1 Preferred Stock
Ansbert Gadicke Ten Percent Owner 08 Mar 2016 718,396 1,856,606 - - Common Stock
Jesse I. Treu Director, Ten Percent Owner 08 Mar 2016 13,925 0 - - Series A-1 Preferred Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 2,674 0 - - Series C-1 Preferred Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 5,641 5,641 - - Common Stock
Ansbert Gadicke Ten Percent Owner 08 Mar 2016 312,085 0 - - Series C-1 Preferred Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 400,422 0 - - Series B-1 Preferred Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 444,460 0 - - Series B-1 Preferred Stock
Jesse I. Treu Director, Ten Percent Owner 08 Mar 2016 13,925 13,925 - - Common Stock
Ansbert Gadicke Ten Percent Owner 08 Mar 2016 718,396 0 - - Series B-1 Preferred Stock
Ansbert Gadicke Ten Percent Owner 08 Mar 2016 312,085 2,168,691 - - Common Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 1,299,394 0 - - Series A-1 Preferred Stock
Jesse I. Treu Ten Percent Owner 08 Mar 2016 761,062 761,062 - - Common Stock
Ivor Royston None 08 Mar 2016 315,195 0 - - Series A-1 Preferred Stock
Ivor Royston None 08 Mar 2016 198,931 514,126 - - Common Stock
Ivor Royston None 08 Mar 2016 198,931 0 - - Series B-1 Preferred Stock
Ivor Royston None 08 Mar 2016 86,419 600,545 - - Common Stock
Ivor Royston None 08 Mar 2016 315,195 315,195 - - Common Stock
Ivor Royston None 08 Mar 2016 86,419 0 - - Series C-1 Preferred Stock
Ivor Royston None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Mar 2016 150,000 750,545 - - Common Stock
Luke B. Evnin Director, Ten Percent Owner 08 Mar 2016 1,138,210 1,138,210 - - Common Stock
Luke B. Evnin Director, Ten Percent Owner 08 Mar 2016 1,138,210 0 - - Series A-1 Preferred Stock
Luke B. Evnin Director, Ten Percent Owner 08 Mar 2016 718,396 1,856,606 - - Common Stock
Luke B. Evnin Director, Ten Percent Owner 08 Mar 2016 312,085 0 - - Series C-1 Preferred Stock
Luke B. Evnin Director, Ten Percent Owner 08 Mar 2016 718,396 0 - - Series B-1 Preferred Stock
Luke B. Evnin Director, Ten Percent Owner 08 Mar 2016 312,085 2,168,691 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters